HuGE Literature Finder
Records
1
-
30
USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer. Journal of Zhejiang University. Science. B 2023 2 24 (2): 143-156. Yang Dexin, Feng Yuqin, Lu Haohua, Chen Kelie, Xu Jinming, Li Peiwei, Wang Tianru, Xia Dajing, Wu Yih |
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles. Clinical lung cancer 2022 Jul . Hsu Robert, Herrmann Amanda, Gaur Kush, Xia Bing, Nieva Jorge |
Computed tomography-guided lung biopsy for molecular tests: a meta-analysis. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101. Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab. Translational lung cancer research 2022 9 11 (8): 1619-1630. Shen Yinchen, Li Jiaqi, Qiang Huiping, Lei Yuqiong, Chang Qing, Zhong Runbo, Stella Giulia Maria, Gelsomino Francesco, Kim Yeon Wook, Abed Afaf, Qian Jialin, Chu Tianqi |
Clinical predictors of treatment efficacy and a prognostic nomogram in patients with lung adenocarcinoma receiving immune checkpoint inhibitors: a retrospective study. Journal of thoracic disease 2022 11 14 (10): 4096-4112. Hu Fang, Peng Jin, Niu Yanjie, Mao Xiaowei, Zhao Yizhuo, Jiang Liy |
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia. BMC research notes 2022 12 15 (1): 369. Heriyanto Didik Setyo, Laiman Vincent, Limantara Nikko Vanda, Anantawikrama Widyan Putra, Yuliani Fara Silvia, Cempaka Rita, Anwar Sumadi Lukm |
Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort. Translational cancer research 2022 2 8 (1): 255-261. Wang Zeng, Jiang Zhiming, Lu Hongya |
The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer. World journal of oncology 2022 5 13 (2): 84-95. Zhu Dao Qi, Liu Ying, Yu Zhi Jian, Zhang Ru Hua, Li Ai Wu, Gong Feng Ying, Wang Wei, Xiao Wei, Fan Q |
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
Genomic landscape of ground glass opacities (GGOs) in East Asians. Journal of thoracic disease 2021 Apr 13 (4): 2393-2403. Cao Peng, Hu Shan, Kong Kangle, Han Peng, Yue Jiaqi, Deng Yu, Zhao Bo, Li F |
Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis. Medicine 2021 Mar 100 (10): e19713. Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa |
The utility of the Ion Torrent PGM next generation sequencing for analysis of the most commonly mutated genes among patients with colorectal cancer in India. Indian journal of cancer 2021 Mar . Mehra Simmi, Tiwari Aseem Kumar, Mehta Swati Pabbi, Sachdev Ritesh, Rajvanshi Chhavi, Chauhan Rajni, Saini Abhishek, Vaid Ash |
Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib. Translational lung cancer research 2021 4 10 (3): 1525-1535. Li Jingjing, Zhang Bin, Zhang Yu, Xu Feng, Zhang Zhenfa, Shao Lin, Yan Chunhe, Ulivi Paola, Denis Marc G, Christopoulos Petros, Thomas de Montpréville Vincent, Bernicker Eric H, van der Wekken Anthonie J, Wang Changli, Yue Dongshe |
Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World journal of gastroenterology 2021 10 27 (36): 6093-6109. Rah Bilal, Banday Manzoor Ahmad, Bhat Gh Rasool, Shah Omar J, Jeelani Humira, Kawoosa Fizalah, Yousuf Tahira, Afroze D |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients. Frontiers in oncology 2021 4 11 647598. Yang Jie, Li Hefei, Li Ben, Li Wei, Guo Qiang, Hu Ling, Song Zizheng, Zhou B |
Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies. Annals of palliative medicine 2021 4 10 (4): 3657-3672. Chen Shanshan, Hua Xin, Jia Jinfang, Wu Ying, Wei Shuzhen, Xu Lu, Han Shuhua, Zhang Hongming, Zhu Xiao |
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
[Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 4 23 (5): 337-342. Hu Ying, Yang Xinjie, Nie Lihui, Zhao Dan, An Jun, Li Baol |
Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma. Molecular and clinical oncology 2020 8 13 (3): 12. Phruttinarakorn Bantita, Reungwetwattana Thanyanan, Incharoen Pimp |
Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan. BMJ open 2020 9 10 (9): e035615. Ogawa Koichi, Koh Yasuhiro, Kaneda Hiroyasu, Izumi Motohiro, Matsumoto Yoshiya, Sawa Kenji, Fukui Mitsuru, Taniguchi Yoshihiko, Yoshimoto Naoki, Tamiya Akihiro, Ando Masahiko, Kubo Akihito, Isa Shun-Ichi, Saka Hideo, Matsumura Akihide, Kawaguchi Tomo |
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers 2020 12 12 (12): . Geraud Arthur, Mezquita Laura, Auclin Edouard, Combarel David, Delahousse Julia, Gougis Paul, Massard Christophe, Jovelet Cécile, Caramella Caroline, Adam Julien, Naltet Charles, Lavaud Pernelle, Gazzah Anas, Lacroix Ludovic, Rouleau Etienne, Vasseur Damien, Mir Olivier, Planchard David, Paci Angelo, Besse Benjam |
Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas. Acta cytologica 2020 8 65 (1): 67-74. Nambirajan Aruna, Dutta Rimlee, Malik Prabhat Singh, Bubendorf Lukas, Jain Deepa |
Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer. JCO precision oncology 2020 10 4 . Bouchahda Mohamed, Saffroy Raphael, Karaboué Abdoulaye, Hamelin Jocelyne, Innominato Pasquale, Saliba Faouzi, Lévi Francis, Bosselut Nelly, Lemoine Antoinet |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: